Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Galenica AG ( (CH:GALE) ) just unveiled an update.
Galenica AG is launching a new pharmacy concept at the Amavita pharmacy in Glattzentrum Zurich, aimed at enhancing customer experience and consultation services. This initiative is part of Galenica’s strategy to integrate digital and physical services, addressing changing customer needs and positioning pharmacies as central healthcare hubs. The pilot project will provide insights for future expansions, with further implementations planned for 2026.
The most recent analyst rating on (CH:GALE) stock is a Hold with a CHF93.00 price target. To see the full list of analyst forecasts on Galenica AG stock, see the CH:GALE Stock Forecast page.
More about Galenica AG
Galenica AG is a prominent player in the Swiss healthcare industry, providing a comprehensive range of services including pharmacies, pharmaceutical logistics, and home care. With approximately 8,000 employees, Galenica is well-positioned in the market, focusing on shaping the future of healthcare in Switzerland through innovation and collaboration with strong partners.
Average Trading Volume: 77,459
Technical Sentiment Signal: Buy
Current Market Cap: CHF4.42B
Find detailed analytics on GALE stock on TipRanks’ Stock Analysis page.